Suguru Hasegawa
Papers
7
Total Citations
68
H-Index
5
About
Suguru Hasegawa is a prominent surgical oncologist whose research centers on minimally invasive approaches to colorectal and hepatic surgery, with particular emphasis on rectal cancer surgery, robotic-assisted techniques, and surgical quality outcomes. His work has made significant contributions to advancing laparoscopic and robotic surgery for locally advanced rectal cancer, most notably through leadership of landmark multicenter prospective trials. The PRODUCT trial (2022, 19 citations) established rigorous quality benchmarks for laparoscopic rectal cancer surgery in Japan using circumferential resection margin assessment, while the VITRUVIANO trial (2024, 17 citations) prospectively evaluated robotic-assisted surgery with standardized surgeon criteria — addressing a critical gap in the literature. Hasegawa has also pioneered innovative hepatic surgical techniques, developing a saline-linked bipolar clamp-crush method for robotic liver resection that elegantly solves the persistent challenge of tissue adhesion during parenchymal transection. His engagement with patient-centered outcomes is demonstrated through the LANDMARC study, which systematically investigates sexual dysfunction following minimally invasive rectal surgery. Spanning technical innovation, multicenter trial design, and quality-of-life research, Hasegawa's body of work has meaningfully shaped evidence-based practice in surgical oncology across Japan and internationally.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4Transanal TME: new standard or fad?9 citations · 2019
- 5
- 6
- 7